The Human Growth Hormone test: a war of words between the World Anti-Doping Agency and the NFL Players Association
The World Anti-Doping Agency (“WADA”) and the National Football League Players’ Association (“NFLPA”) have been in a long running debate over the application of Human Growth Hormone (“HGH”) blood testing in the National Football League (“NFL”). Howard Jacobs (The Athletes Lawyer) reviews both sides of the debate in light of the recent the Court of Arbitration for Sport decision in the Veerpalu v. FIS case.
To continue reading or watching login or register here
Already a member? Sign in
Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts. Find out more here.
- Tags: Anti-Doping | National Football League (NFL) | NFL Players Association (NFLPA) | United States of America (USA) | World Anti-Doping Agency (WADA)
Related Articles
- The Athlete Biological Passport: a ‘magic bullet’ for EPO detection? Part 1 of 2
- The Athlete Biological Passport: a ‘magic bullet’ for EPO detection? Part 2 of 2
- Navigating the WADA prohibited list: catchalls and consistencies
- Catch me if you can! Anti-doping policy in India
- Rope-a-dope: the continued fight against doping in sport
